The Supreme Court Rejects The Case Challenging Access To The Abortion Drug Mifepristone, But Reproductive Care Is Still On The Chopping Block.
Washington, D.C. — In a major decision, the Supreme Court rejected a challenge to abortion medication drug mifepristone in FDA v. Alliance for Hippocratic Medicine and Danco v. Alliance for Hippocratic Medicine, holding that the plaintiffs lack standing. Th...
